Advanced BioPhotonics, Inc., Advanced Viral Research Corp., Brantley Capital Corp., Brilliant Technologies Corporation, 4C Controls, Inc., and 2-Track Global, Inc.; Order of Suspension of Trading, 19744-19745 [2012-7942]
Download as PDF
<![CDATA[
19744
Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices
While changes to the Pricing
Schedule pursuant to this proposal are
effective upon filing, the Exchange has
designated these changes to be operative
on June 1, 2012.
2. Statutory Basis
The Exchange believes that its
proposal to amend its Pricing Schedule
is consistent with Section 6(b) of the
Act 5 in general, and furthers the
objectives of Section 6(b)(4) of the Act 6
in particular, in that it is an equitable
allocation of reasonable fees and other
charges among Exchange members. The
Exchange believes that the fee change is
reasonable because the Exchange’s
collection of ORF has declined due to a
decrease in industry volume and the
adjustment would serve to provide the
Exchange with additional ORF. The
additional ORF offsets regulatory
expenses, but does not exceed
regulatory costs.
The Exchange believes that the ORF is
equitable and not unfairly
discriminatory because it is objectively
allocated to Exchange members in that
it would continue to be charged to all
members on all of their transactions that
clear as customer at OCC. The Exchange
is assessing higher fees to those member
firms that require more Exchange
regulatory services based on the amount
of customer options business they
conduct. In addition, the ORF seeks to
recover the costs of supervising and
regulating members, including
performing routine surveillances,
investigations, examinations, financial
monitoring, and policy, rulemaking,
interpretive, and enforcement activities.
The ORF is not charged for member
proprietary options transactions because
members incur the costs of owning
memberships and through their
memberships are charged transaction
fees, dues and other fees that are not
applicable to non-members.
Additionally, the dues and fees paid by
members go into the general funds of
the Exchange, a portion of which is used
to help pay the costs of regulation.
mstockstill on DSK4VPTVN1PROD with NOTICES
B. Self-Regulatory Organization’s
Statement on Burden on Competition
The Exchange does not believe that
the proposed rule change will impose
any burden on competition not
necessary or appropriate in furtherance
of the purposes of the Act.
5 15
6 15
U.S.C. 78f(b).
U.S.C. 78f(b)(4).
VerDate Mar<15>2010
17:42 Mar 30, 2012
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants, or Others
No written comments were either
solicited or received.
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
The foregoing rule change has become
effective pursuant to Section
19(b)(3)(A)(ii) of the Act.7 At any time
within 60 days of the filing of the
proposed rule change, the Commission
summarily may temporarily suspend
such rule change if it appears to the
Commission that such action is
necessary or appropriate in the public
interest, for the protection of investors,
or otherwise in furtherance of the
purposes of the Act. If the Commission
takes such action, the Commission shall
institute proceedings to determine
whether the proposed rule should be
approved or disapproved.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
Electronic Comments
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an email to rulecomments@sec.gov. Please include File
Number SR–Phlx–2012–36 on the
subject line.
Paper Comments
• Send paper comments in triplicate
to Elizabeth M. Murphy, Secretary,
Securities and Exchange Commission,
100 F Street NE., Washington, DC
20549–1090.
All submissions should refer to File
Number SR–Phlx–2012–36. This file
number should be included on the
subject line if email is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
7 15
Jkt 226001
PO 00000
U.S.C. 78s(b)(3)(A)(ii).
Frm 00135
Fmt 4703
Sfmt 4703
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for Web site viewing and
printing in the Commission’s Public
Reference Room, 100 F Street NE.,
Washington, DC 20549, on official
business days between the hours of
10 a.m. and 3 p.m. Copies of the filing
also will be available for inspection and
copying at the principal office of the
Exchange. All comments received will
be posted without change; the
Commission does not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly. All submissions
should refer to File Number SR–Phlx–
2012–36 and should be submitted on or
before April 23, 2012.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.8
Kevin M. O’Neill,
Deputy Secretary.
[FR Doc. 2012–7771 Filed 3–30–12; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
Advanced BioPhotonics, Inc.,
Advanced Viral Research Corp.,
Brantley Capital Corp., Brilliant
Technologies Corporation, 4C
Controls, Inc., and 2–Track Global,
Inc.; Order of Suspension of Trading
March 29, 2012.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Advanced
BioPhotonics, Inc. because it has not
filed any periodic reports since the
period ended September 30, 2007.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Advanced
Viral Research Corp. because it has not
filed any periodic reports since the
period ended September 30, 2008.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Brantley
Capital Corp. because it has not filed
any periodic reports since the period
ended September 30, 2004.
It appears to the Securities and
Exchange Commission that there is a
8 17
E:\FR\FM\02APN1.SGM
CFR 200.30–3(a)(12).
02APN1
Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices
lack of current and accurate information
concerning the securities of Brilliant
Technologies Corporation because it has
not filed any periodic reports since the
period ended March 31, 2007.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of 4C Controls,
Inc. because it has not filed any periodic
reports since the period ended
September 30, 2009.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of 2–Track
Global, Inc. because it has not filed any
periodic reports since the period ended
September 30, 2009.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above-listed
companies. Therefore, it is ordered,
pursuant to Section 12(k) of the
Securities Exchange Act of 1934, that
trading in the securities of the abovelisted companies is suspended for the
period from 9:30 a.m. EDT on March 29,
2012, and terminating at 11:59 p.m. EDT
on April 12, 2012.
By the Commission.
Jill M. Peterson,
Assistant Secretary.
BILLING CODE 8011–01–P
OFFICE OF THE UNITED STATES
TRADE REPRESENTATIVE
Office of the United States
Trade Representative.
ACTION: Notice; request for comments.
AGENCY:
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
March 29, 2012.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Angstrom
Microsystems Corp. because it has not
filed any periodic reports since the
period ended September 30, 2008.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Bedminster
National Corp. because it has not filed
any periodic reports since the period
ended September 30, 2008.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of Brake
Headquarters U.S.A., Inc. because it has
Jkt 226001
The Office of the United
States Trade Representative (AUSTR@)
is providing notice that on February 21,
2012, the Socialist Republic of Vietnam
(‘‘Vietnam’’) requested consultations
with the United States under the
Marrakesh Agreement Establishing the
World Trade Organization (AWTO
Agreement@) concerning certain
antidumping administrative reviews
and a sunset review conducted by the
Department of Commerce on imports of
certain frozen warmwater shrimp from
Vietnam (Investigation A–552–802), and
various U.S. laws, regulations,
administrative procedures, practices,
and methodologies. That request may be
found at www.wto.org contained in a
document designated as WT/DS429/1.
USTR invites written comments from
the public concerning the issues raised
in this dispute.
DATES: Although USTR will accept any
comments received during the course of
the dispute settlement proceedings,
comments should be submitted on or
SUMMARY:
Angstrom Microsystems Corp.,
Bedminster National Corp., Brake
Headquarters U.S.A., Inc., and
BrandPartners Group, Inc.; Order of
Suspension of Trading
mstockstill on DSK4VPTVN1PROD with NOTICES
[FR Doc. 2012–7943 Filed 3–29–12; 4:15 pm]
WTO Dispute Settlement Proceeding
Regarding United States; AntiDumping Measures on Certain Shrimp
from Viet Nam
BILLING CODE 8011–01–P
17:42 Mar 30, 2012
By the Commission.
Jill M. Peterson,
Secretary.
[Dispute No. WTO/DS429]
[FR Doc. 2012–7942 Filed 3–29–12; 4:15 pm]
VerDate Mar<15>2010
not filed any periodic reports since the
period ended September 30, 1998.
It appears to the Securities and
Exchange Commission that there is a
lack of current and accurate information
concerning the securities of
BrandPartners Group, Inc. because it has
not filed any periodic reports since the
period ended September 30, 2009.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above-listed
companies. Therefore, it is ordered,
pursuant to Section 12(k) of the
Securities Exchange Act of 1934, that
trading in the securities of the abovelisted companies is suspended for the
period from 9:30 a.m. EDT on March 29,
2012, and terminating at 11:59 p.m. EDT
on April 12, 2012.
PO 00000
Frm 00136
Fmt 4703
Sfmt 4703
19745
before April 13, 2012, to be assured of
timely consideration by USTR.
ADDRESSES: Public comments should be
submitted electronically using
www.regulations.gov, docket number
USTR–2012–0003. If you are unable to
provide submissions using
www.regulations.gov, please contact
Sandy McKinzy at (202) 395–9483 to
arrange for an alternative method of
transmission.
If (as explained below) the comment
contains confidential information, then
the comment should be submitted by
fax only to Sandy McKinzy at (202)
395–3640.
FOR FURTHER INFORMATION CONTACT:
J. Daniel Stirk, Associate General
Counsel, Office of the United States
Trade Representative, 600 17th Street
NW., Washington, DC 20508, (202) 395–
3150.
SUPPLEMENTARY INFORMATION: USTR is
providing notice that consultations have
been requested pursuant to the WTO
Understanding on Rules and Procedures
Governing the Settlement of Disputes
(‘‘DSU’’). If such consultations should
fail to resolve the matter and a dispute
settlement panel is established pursuant
to the DSU, such panel, which would
hold its meetings in Geneva,
Switzerland, would be expected to issue
a report on its findings and
recommendations within nine months
after it is established.
Major Issues Raised by Vietnam
On February 21, 2012, Vietnam
requested consultations regarding
certain antidumping administrative
reviews and a sunset review conducted
by the Department of Commerce on
certain frozen warmwater shrimp from
Vietnam, referring in particular to the
use of what it describes as ‘‘zeroing’’ in
those reviews. Specifically, Vietnam
challenges (1) the imposition of
antidumping duties and cash deposit
requirements pursuant to the final
results of the fourth administrative
review for the period from February 1,
2008, to January 31, 2009, in Certain
Frozen Warmwater Shrimp From the
Socialist Republic of Vietnam: Final
Results and Partial Rescission of
Antidumping Duty Administrative
Review, 75 FR 47771 (August 9, 2010);
(2) the fourth administrative review of
Certain Frozen Warmwater Shrimp
From the Socialist Republic of Vietnam
insofar as it did not revoke the
antidumping duty order with respect to
certain respondents requesting such
revocation; (3) the imposition of
antidumping duties and cash deposit
requirements pursuant to the final
results of the fifth administrative review
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Pages 19744-19745]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7942]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[File No. 500-1]
Advanced BioPhotonics, Inc., Advanced Viral Research Corp.,
Brantley Capital Corp., Brilliant Technologies Corporation, 4C
Controls, Inc., and 2-Track Global, Inc.; Order of Suspension of
Trading
March 29, 2012.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Advanced BioPhotonics, Inc. because it has not filed any periodic
reports since the period ended September 30, 2007.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Advanced Viral Research Corp. because it has not filed any periodic
reports since the period ended September 30, 2008.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Brantley Capital Corp. because it has not filed any periodic reports
since the period ended September 30, 2004.
It appears to the Securities and Exchange Commission that there is
a
[[Page 19745]]
lack of current and accurate information concerning the securities of
Brilliant Technologies Corporation because it has not filed any
periodic reports since the period ended March 31, 2007.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
4C Controls, Inc. because it has not filed any periodic reports since
the period ended September 30, 2009.
It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
2-Track Global, Inc. because it has not filed any periodic reports
since the period ended September 30, 2009.
The Commission is of the opinion that the public interest and the
protection of investors require a suspension of trading in the
securities of the above-listed companies. Therefore, it is ordered,
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that
trading in the securities of the above-listed companies is suspended
for the period from 9:30 a.m. EDT on March 29, 2012, and terminating at
11:59 p.m. EDT on April 12, 2012.
By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2012-7942 Filed 3-29-12; 4:15 pm]
BILLING CODE 8011-01-P
